Thus, this study aimed to assess the effectiveness of intranasal mitochondrial transplantation in treating a UQCRC1 mutant model of PD, and to compare the treatment outcomes between mitochondria pretreated with CsA and those without pretreatment. The gene discussed is UQCRC1; the disease is Parkinson disease.